Related Experiment Videos
Is xamoterol safe in chronic airflow obstruction?
J A Roberts1, V F Challenor, D G Waller
1Clinical Pharmacology, Southampton General Hospital, UK.
European Journal of Clinical Pharmacology
|January 1, 1992
Abstract:
We have demonstrated in a group of 10 patients with CAO that treatment with xamoterol (200 mg b.i.d. for 7 days) did not alter lung function or respiratory symptoms. These results suggest that xamoterol can be used to treat mild heart failure in patients with CAO.